Liquid chromatography–tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma

Title
Liquid chromatography–tandem mass spectrometric assay for the T790M mutant EGFR inhibitor osimertinib (AZD9291) in human plasma
Authors
Keywords
Osimertinib, Non-small cell lung carcinoma, LC–MS/MS, Human plasma, Salting-out assisted liquid–liquid extraction
Publisher
Elsevier BV
Online
2016-07-20
DOI
10.1016/j.jchromb.2016.07.037

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now